Covaxin effective against mutant COVID-19 strain from UK: Bharat Biotech
The findings are in an article on the website of bioRxiv, which said these are preliminary reports that have not been peer-reviewed.
Photo via @BharatBiotech on Twitter
Covaxin - the vaccine developed by Hyderabad-based Bharat Biotech - is effective against UK variants of COVID-19, according to a study on 26 participants, shared by the company on Wednesday.
The findings are in an article - Neutralization of UK-variant VUI-202012/01 with Covaxin vaccinated human serum - on the website of bioRxiv, which said these are preliminary reports that have not been peer-reviewed. A comparable neutralization activity of sera of the vaccinated individuals showed against UK-variant and the heterologous strain with similar efficiency, dispel the uncertainty of possible neutralization escape, the article said.
Covaxin Effective Against UK Variants Of Covid-19: Study
Covaxin has been accorded approval for restricted emergency use in the country by the Drugs Controller General of India (DCGI) on January 3. PTI Photo/Shailendra Bhojak outlookindia.com 2021-01-27T20:08:48+05:30
Also read
The archive is operated by Cold Spring Harbor Laboratory, not-for-profit research and educational institution in New York.
The bioRxiv website article - Neutralization of UK-variant VUI-202012/01 with Covaxin vaccinated human serum - shared the findings of the study and said these are preliminary reports that have not been peer-reviewed. A comparable neutralization activity of sera of the vaccinated individuals showed against UK-variant and the heterologous strain with similar efficiency, dispel the uncertainty of possible neutralization escape, the article said.
Covaxin successful against UK variants of COVID-19: Bharat Biotech Agencies
New Delhi: The Covaxin vaccine developed by Hyderabad-based Bharat Biotech is effective against UK variants of COVID-19. This information was shared Wednesday by Bharat Biotech after a study on 26 participants.
The findings are in an article – Neutralization of UK-variant VUI-202012/01 with Covaxin vaccinated human serum – on the website of bioRxiv, which said these are preliminary reports that have not been peer-reviewed.
“A comparable neutralization activity of sera of the vaccinated individuals showed against UK-variant and the heterologous strain with similar efficiency, dispel the uncertainty of possible neutralization escape,” the article said.
Over 16 lakh healthcare workers across the country have received Covid-19 vaccine shots till Sunday evening, as per provisional reports, the Union Health Ministry said in a statement.